cabergoline has been researched along with Aortic Incompetence in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (88.89) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belleville, I; Boujon, B; Chagué, F; Petit, JM | 2 |
Becher, H; Herring, N; Karavitaki, N; Szmigielski, C; Wass, JA | 1 |
Assayag, P; Bouchachi, A; Chanson, P; Garcia, C; Kallel, N; Maione, L; Maison, P; Salenave, S; Young, J | 1 |
Erginöz, E; Kenangil, G; Koldas, L; Ozekmekçi, S; Sahin, T | 1 |
Flannery, D; Lyons, K | 1 |
Daida, H; Hatano, T; Hattori, N; Iwama, Y; Komine-Kobayashi, M; Mizuno, Y; Mochizuki, H; Nakayama, T; Sakai, M; Urabe, T; Yamashiro, K | 1 |
Bogazzi, F; Boresi, F; Buralli, S; Cigni, T; Lombardi, M; Manetti, L; Martino, E; Raffaelli, V; Salvetti, A; Taddei, S | 1 |
9 other study(ies) available for cabergoline and Aortic Incompetence
Article | Year |
---|---|
[An aortic insufficiency diagnosed under cabergoline].
Topics: Aortic Valve Insufficiency; Cabergoline; Ergolines; Female; Humans; Hyperprolactinemia; Middle Aged | 2009 |
Valvular heart disease and the use of cabergoline for the treatment of prolactinoma.
Topics: Aortic Valve Insufficiency; Cabergoline; Calcinosis; Echocardiography; Ergolines; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Prolactinoma; Ventricular Dysfunction, Left | 2009 |
The older Parkinson's disease drugs pergolide and cabergoline have been linked to heart problems. Are there any new Parkinson's drugs which are safer for patients with heart risks?
Topics: Antiparkinson Agents; Aortic Valve Insufficiency; Cabergoline; Dopamine Agonists; Ergolines; Health Knowledge, Attitudes, Practice; Humans; Parkinson Disease; Pergolide | 2009 |
No evidence of a detrimental effect of cabergoline therapy on cardiac valves in patients with acromegaly.
Topics: Acromegaly; Adolescent; Adult; Aged; Aortic Valve Insufficiency; Cabergoline; Cross-Sectional Studies; Dopamine Agonists; Echocardiography; Echocardiography, Doppler; Ergolines; Female; Heart Valve Diseases; Heart Valves; Humans; Hypertrophy, Left Ventricular; Longitudinal Studies; Male; Middle Aged; Mitral Valve Insufficiency; Retrospective Studies; Tricuspid Valve Insufficiency; Young Adult | 2012 |
Assessment of valvulopathy in Parkinson's disease patients on pergolide and/or cabergoline.
Topics: Aged; Antiparkinson Agents; Aortic Valve Insufficiency; Cabergoline; Dopamine Agonists; Drug Therapy, Combination; Echocardiography; Ergolines; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Parkinson Disease; Pergolide; Retrospective Studies; Tricuspid Valve Insufficiency | 2007 |
[Aortic insufficiency under weak doses of cabergoline for non-tumoral hyperprolactinemia].
Topics: Aortic Valve Insufficiency; Cabergoline; Diagnosis, Differential; Dopamine Agents; Ergolines; Female; Heart Valve Diseases; Humans; Hyperprolactinemia; Middle Aged; Receptor, Serotonin, 5-HT2B | 2007 |
Aortic regurgitation associated with cabergoline therapy.
Topics: Aortic Valve Insufficiency; Cabergoline; Dopamine Agonists; Dyspnea; Ergolines; Humans; Lewy Body Disease; Male; Middle Aged; Ultrasonography | 2008 |
The frequency of cardiac valvular regurgitation in Parkinson's disease.
Topics: Aged; Aortic Valve Insufficiency; Azepines; Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Male; Mitral Valve Insufficiency; Parkinson Disease; Pergolide; Pramipexole; Prevalence | 2008 |
Treatment with low doses of cabergoline is not associated with increased prevalence of cardiac valve regurgitation in patients with hyperprolactinaemia.
Topics: Adult; Aortic Valve Insufficiency; Cabergoline; Case-Control Studies; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Male; Mitral Valve Insufficiency; Risk Factors; Tricuspid Valve Insufficiency | 2008 |